Prostate Cancer

Latest news and analysis on Prostate Cancer

Equities

Radiopharmaceuticals: Prostate cancer diagnostic revenues currently in focus, but the opportunity in therapeutics could be larger

In this wire we go beyond the immediate opportunity in diagnostics and review the landscape for prostate cancer radiotherapeutics.
+4
Charlie Williams
HB Biotechnology
1
Elf Footer